These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1381319)

  • 1. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
    Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
    Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
    Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of SR 142801 at peripheral tachykinin receptors.
    Patacchini R; Barthò L; Holzer P; Maggi CA
    Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison in different tissue preparations of the in vitro pharmacological profile of RP 67580, a new non-peptide substance P antagonist.
    Carruette A; Moussaoui SM; Champion A; Cottez D; Goniot P; Garret C
    Neuropeptides; 1992 Dec; 23(4):245-50. PubMed ID: 1282222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
    Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J
    Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
    Maggi CA; Patacchini R; Feng DM; Folkers K
    Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
    Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
    Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist.
    Maggi CA; Patacchini R; Giuliani S; Giachetti A
    Eur J Pharmacol; 1993 Mar; 234(1):83-90. PubMed ID: 8386095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of (+/-) CP 96,345 and L-668,169 on neurokinin receptor mediated responses in rat and guinea-pig isolated tissues.
    Razzaque Z; Longmore J
    Neuropeptides; 1993 Sep; 25(3):169-74. PubMed ID: 7504215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of NK receptors in guinea-pig urinary bladder smooth muscle: use of selective antagonists.
    Longmore J; Hill RG
    Eur J Pharmacol; 1992 Nov; 222(1):167-70. PubMed ID: 1281775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
    Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
    Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological assessment of spantide II analogues.
    Wang ZY; Feng DM; Wang YL; Tung SR; Wong K; Strichartz GR; Folkers K; Håkanson R
    Eur J Pharmacol; 1994 Aug; 260(2-3):121-8. PubMed ID: 7527343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.